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Obesity and insulin resistance: lessons learned from the Pima Indians
Abstract
Diabetes and obesity are epidemic in the Pima Indians of the Southwestern United States, and the
prevalence of diabetes is increasing. The most likely link between obesity and diabetes is tissue insulin
resistance. If obesity is defined as an excess of body fat, then it can only be accurately assessed by
measurements of body composition and not by approximations such as body mass index or percent of
ideal weight. To compare the metabolic data of individuals of varying size, an accurate measure of
metabolic size is needed. Total body weight is not an appropriate means of comparing individuals since
obese subjects have a greater proportion of nonmetabolizing mass (triglyceride). Body surface area
shows a sex difference, and this may distort data if both sexes are present. From studies of metabolic
rate we have determined that metabolic rate is indirectly proportional to the fat-free mass plus 18 kg, and
we suggest that this weight can be equated with metabolic size. Glucose storage in skeletal muscle
appears to be important in the disposal of an intravenous glucose load. Consistent with its role in
glycogen storage, glycogen synthase enzyme is activated in proportion to the ability to dispose of glucose
during a hyperinsulinemic, euglycemic clamp. The role of glycogen synthase is most notable at
supraphysiological plasma insulin concentrations; and since glucose uptake at these insulin
concentrations is highly familial independent of the degree of obesity, we suggest that there may be a
specific genetic defect expressed in skeletal muscle that reduces insulin responsiveness in some
subjects. The lack of correlation between 24 hour respiratory quotient measured in a metabolic chamber
(a measure of the proportion of fat derived calories) and degree of obesity indicates that in obese Pima
Indians insulin resistance is not due to an inhibition of glucose metabolism by free fatty acids (glucosefatty acid-ketone cycle). Obesity is associated with an increase in fat-free mass almost kilogram- for
kilogram with fat mass when compared to the lean state. A role for this increase in fat-free tissue in
producing insulin resistance has been given insufficient attention in the past. With an increase in fat-free
mass, muscle cells are hypertrophied and capillaries in muscle are more widely spaced. We propose that
these biophysical changes in muscle mediate, at least in part, the effects of obesity to produce a
reduction in insulin sensitivity and the abnormal kinetics of insulin action found in the obese. We suggest
therefore that insulin resistance is a combination of a genetic defect and obesity-induced changes in the
biophysical properties of skeletal muscle. These defects may in turn lead to the development of noninsulin-dependent diabetes mellitus.
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Obesity and Insulin Resistance: Lessons Learned from the
Pima Indians
S. Lillioja and C. Bogardus

Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, Phoenix, Arizona 85016

I. INTRODUCTION
Obesity is so frequently a feature of persons
with non-insulin-dependent diabetes mellitus that
Ethan A. H. Sims coined the team diabesity to
describe this increasingly occurring syndrome.
The reasons for the association of these two metabolic disorders are not fully known, but it is
hypothesized to be a result of the association of
obesity with insulin resistance, which is a common
finding in subjects with non-insulin-dependent
diabetes mellitus. In this brief report we will review data from studies performed with the cooperation of the Pima Indians of the Gila River Indian
Community that are relevant to an increased understanding of the relationship of obesity and
insulin resistance.

11. BACKGROUND AND EPIDEMIOLOGIC
STUDIES
The Pima Indians are a relatively genetically
homogeneous population' whose ancestors have
lived in the same arid environment in central
Arizona for about 2,000 years. The current study
population consists of over 4,000 individuals who
are at least one-half Pima heritage, are at least 5
years of age, and reside on the Gila River Indian
Reservation. They are examined every 2 years and
the examination includes an oral glucose tolerance
test (75 grams). Diabetes mellitus is diagnosed
according to the 1985 WHO criteria' at a survey
examination or in the course of routine medical
care. The diabetes in the Pima is not ketosis-prone,
not associated with islet-cell antibodies, and is
therefore, even in the young, entirely non-insulindependent diabetes m e l l i t ~ s . As
~ , ~late as 1940,
only 21 Pima Indians were identified with diabetes
DiabetesiMetabolism Reviews, Vol. 4, No. 5, 517-540 (1988)
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and it was concluded that diabetes prevalence was
similar in American Indians and the general popul a t i ~ n .Only
~
since the 1950s has diabetes been
reported as an unusually frequent disease among
the Pimas.6 By the 1970s, 40% of the males aged
45-74 years and 68% of the females aged 55-64
years had diabetes (Figure l),' and between then
and 1980 the prevalence rates continued to increase. In the mid-1970s the diabetes incidence
rate, age- and sex-adjusted to the 1970 U.S. Caucasian population, was 26.5 1.9 cases/per 1,000
person-years (rate ? S.E.), 19 times the rate in
Rochester, M i n n e ~ o t a .The
~ incidence rates increased further by the mid-l980s.*
The Pimas are also commonly obese. The
mean body mass indices-weight (kg) divided by
height (mete?)-of
males and females exceed
those of the U.S. population at all ages (Figure 2).9
Longitudinal studies showed that the incidence of
diabetes increases with increasing body mass index.' This observation was essential in demonstrating the pathophysiologic relevance of the high
prevalence of obesity to the high prevalence of
diabetes.
However, obesity is not the only risk factor for
the development of diabetes mellitus among the
Pimas. There are Pimas who are obese and do not
have diabetes. Obesity is therefore not a sufficient
abnormality to cause diabetes. Other risk factors
for the development of diabetes among the Pimas,
independent of degree of obesity, include duration
of obesity," and parental diabetes status (Figure
3).9 The mechanisms of the association of obesity
duration and parental diabetes with increased risk
of diabetes are currently unknown, but insulin
resistance has been hypothesized as the mechanism of the association of obesity with an increased risk of diabetes.

*
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Figure 1, Prevalence of DM in Pima Indians (from Knowler et a17).

111. RELATIONSHIP BETWEEN OBESITY AND
INSULIN RESISTANCE

Obesity has frequently been associated with
insulin resistance,”-14 but few investigators have
carefully examined the relationship of degree of
obesity with insulin resistance in a large number of
subjects representing a broad range of body composition. A major, and infrequently discussed,
problem in such studies of obesity and insulin
action is how to appropriately estimate degree of
obesity, and, equally important, how to compare
rates of insulin-mediated glucose disposal among
subjects of different body sizes. In the past 5 years
we have addressed these issues as part of our
metabolic studies of the Pimas.
A. Estimating Degrees of Obesity

The word ”obesity” is derived from Latin,
ob-over and edere-to eat. It is defined as an excess
of body fat. How much excess of body fat mass is
sufficient to label someone obese is arguable since
it requires an arbitrary limit, or cut-off point, of a

continuously distributed variable. Also, the definition of excess body fat necessitates expressing
degree of obesity in relative rather than absolute
terms. For example, a Y-fOOt, 100-kg male with a
15-kg fat mass (15% body fat) is leaner than a
4-foot, 50-kg female with a similar absolute body
fat mass (30% body fat). Degree of obesity is
therefore expressed as a fraction or percentage of
the body mass that is fat. There are many methods
available to assess percent body fat, including:
densitometry underwater weighing, water dilution, total body K’, impedance, etc. Many, but not
all, of these methods require specialized and/or
expensive equipment. Densitometry is a method
readily available to most hospital-based investigators. Subjects can be weighed underwater in the
physical therapist’s water immersion tank, and
residual lung volume can be measured in the
pulmonary lab. It is preferable to measure the
residual lung volume while the subject is immersed in water-but if this is not possible, correction can be made to the residual lung volume
measured in air-with small error.
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Figure 2. Prevalence of obesity (from Knowler et a17).
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Figure 3. Incidence of DM by BMI and parental diabetes in Pima Indians (from Knowler et a19).
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Table 1. Subject Characteristics

Age (yrs)
Height (cm)
Weight (kg)
Surface area (m')
Body mass index (kg/m2)
Body fat (%)
Fat-free body mass (kg)
Waist circumference (inches)
Thigh circumference (inches)
WaisVthigh
Fasting glucose (mg/dl)
2-hr post-load glucose (mg/dl)
Fasting plasma insulin (uU/dl)
2-hr uost-load insulin (uU/ml)
uU

=

Males (n = 117)
Mean S.E.
Range
26 1
18-39
1.71 t- 0.45
1.60-1.82
98.2 t- 25
50.3-188.1
1.52-2.78
2.08 0.02
33.7 0.8
19.2-64.3
28 1
948
44.3-101.0
68.2 t- 1.0
42.2 0.7
25.6-60.0
25.6 0.3
17. a 3 6 . 5
1.64 ? 0.02
1.27-2.08
92 ? 1
73-126
119 ? 2
&188
9-90
33 2
20-1191
181 16

*
*
*
*
*
*

*
*
*

Females (n = 96)
Mean t- S.E.
Range
26 1
18-41
1.59 t- 0.51
i . 4 a i . 70
47.9-131.5
88.9 t- 2.0
1.90 ? 0.02
1.45-2.35
35.0 0.8
19.1-50.4
39 5 1
2G51
53.6 2 0.9
34.8-76.3
42.0 t 0.7
28.4-59.0
26.5 2 0.4
17.5-35.0
1.59 ? 0.02
1.24-2.11
94 1
77-119
136 ? 3
71-199
44t2
11-113
31-816
246 t 15

*
*

"

microunits pu.

Unfortunately, many investigators estimate
percent body fat from measures of body weight
and height, rather than trying to directly assess
body composition. One of the most commonly
used estimates of percent body fat is the body
mass index, or BMI. It is calculated as the body
weight (in kg) divided by height (in meters)
squared. It was first used by Quetelet over 100
years ago. However, he did not use BMI to estimate degree of obesity. As reviewed by Keys et
al.,I5 Quetelet simply noted that weight/height*
was more constant than W/H or W/H3 with increasing height.
Keys et aI.l5 were the first to coin the term
body mass index and to assess its utility as an
estimate of percent body fat. Keys and co-workers
assumed that a good index of percent body fat
should be independent of height-and BMI was.
They then assessed the correlation of BMI with
percent body fat as determined by densitometry.
The studies were performed on 180 collegeaged males (aged 18-24) and an older group of 249
"executive" males (aged 49-59) in Minnesota. In
the younger group, body density significantly correlated with BMI (Y = -0.850), as it did in the older
group ( r = -0.666). BMI therefore satisfied the
authors' criteria for a good index of percent body
fat: It was independent of height and correlated
significantly with percent body fat by densitometry. It was the preferred index since it also
was better correlated with body density than W/H
and W/H3.However, Keys was careful to point out
that BMI was not significantly better correlated
with body density than body weight. In the students, the correlation coefficient between body
density and body weight was -0.777 (as compared

to -0.850 for BMI); and in the executive men was
-0.618 (as compared to -0.666).
We have also examined the relationships between BMI, body weight, and percent body fat by
densitometry among nondiabetic Pima males and
also among nondiabetic Pima females (Table I)
(Figures 5 and 6). The relationship of fat mass and
fat-free mass in a group of nondiabetic Pimas is
also shown (Figure 4). Fat mass and fat-free mass
both increase in obesity. It is apparent from Figure
5 that the relationship between BMI and percent
body fat is not linear, as previously discussed by
Garrow.16 (This is confirmed statistically since in
the linear regression model the coefficient of the
quadratic term is significant, independent of the
coefficient of the linear function.) At the same
BMI, women, on average, have a -10% greater
percentage of body fat compared to men. Among
men, the linear correlation between percent body
fat and BMI was 0.88 ( p < 0.0001)-quite similar to
the correlation observed by Keys et al.I5 in similarly aged men. The correlation is improved by
using a quadratic equation to relate the two variables (Y = 0.91, p < 0.0001). Among Pima females,
the correlation coefficients between percent body
fat and BMI were 0.76 ( p < O.OOOl), using a linear
relationship, and 0.79 ( p < 0.0001) using a quadratic function.
We also analyzed the relationship between
percent body fat and body weight (Figure 6). The
relationship between percent body fat and body
weight is similar to the relationship between percent body fat and BMI, in both males and females.
Among Pima males, the correlation coefficient
between percent body fat and body weight was
0.90 ( p < 0.0001) (using a quadratic model), no
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FAT FREE MASS ( k 9 )
Figure 4. Relationship of fat mass to fat-free mass in 241 nondiabetic Pima Indians. X, females;
males. Slope = 1.15 kg fat mass for each kg fat-free mass. Slopes for both sexes are the same ( p = 0.5 for
a difference). Intercept signficantly greater for females (by 22.4 kg) (p 5 0.0001).
0,

different than the correlation of percent body fat
and BMI (0.91). Similarly, in females, these correlation coefficients were 0.79 and 0.79, respectively. Thus, similar to the findings of Keys et al.,I5
we could not demonstrate that the correlation
between percent body fat and BMI was better than
the correlation of percent body fat and body
weight.
We are aware of no data that have found BMI

to be significantly better correlated to percent body
fat than body weight. Thus, the commonly held
belief that BMI is a better estimate of percent body
fat than body weight is not well-founded. Also, it
is clear that at the same BMI, women are fatter.
Finally, in either sex, the BMI, or body weight,
accounts for only about two-thirds of the variance
of percent body fat. Thus direct, rather than indirect, measures of body composition should be
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Figure 5. The relationship between percent body fat as determined by densitometry and body mass
index in 117 nondiabetic Pima males and 96 nondiabetic Pima females (see Table I for subject
characteristics). In males (a), r = 0.91, p < 0.0001; and in females (X), Y = 0.79, p < 0,0001.
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Figure 6 . The relationship between percent body fat as determined by densitometry and body weight
in 117 nondiabetic Pima males and 96 nondiabetic Pima females (see Table I for subject characteristics).
In males (.), r = 0.90, y < 0.0001; and in females (X), r = 0.79, p < 0.0001.

used to assess body composition in metabolic
studies. This is particularly necessary when attempting to perform correlation analyses between
degree of obesity and other metabolic variables.
Unnecessary error may be introduced by only
estimating percent body fat from means of body
height and weight. In large-scale, populationbased studies, body composition studies may not
be feasible due to the cost and/or time consideration. But certainly metabolic studies with small
study samples involving comparisons of individuals of potentially differing body composition (e.g.,
male vs. female, diabetic vs. nondiabetic) cannot
rely on estimates of body composition and should
make use of direct measurements.

B. Normalizing Data on Insulin Action Among
Lean and Obese Persons
In studies of the relationship between degree
of obesity and insulin action, there is not only the
problem of estimating body composition, but there
is also the problem of how to compare rates of
insulin-mediated glucose disposal between subjects with different body sizes. For example, during an insulin infusion as part of a hyperinsulinemic, euglycemic clamp, the absolute rate of
glucose infusion to maintain euglycemia in a short,
lean, normal glucose tolerant female may be 350
mg/minute. A similar, absolute glucose infusion
rate may be observed in a tall, obese male with
impaired glucose tolerance or diabetes mellitus.

However, since the male has a greater metabolically active tissue mass, it is assumed that he
should consume more glucose than the smaller
female. Thus to compare the rates of insulinmediated glucose disposal rate between these two
subjects the mean rate of glucose disposal must be
normalized to the size of the metabolically active
tissue mass.
The best way to estimate metabolic body size
is to directly measure the body metabolic rate
using direct or indirect calorimetric techniques.
This is rarely done. Most investigators estimate
metabolic body size by calculating body surface
area according to the formula of DuBois and DuBois.17 We have examined the relationship between body surface area and metabolic rate in a
large group of nondiabetic Pima males and females
living on our metabolic ward to examine how well
body surface area correlates with metabolic body
size. Resting metabolic rate was determined by
indirect calorimetry'* in all subjects after they had
lived on our metabolic ward for at least 7 days
while consuming a weight-maintaining diet. Body
surface area is significantly correlated with the
resting metabolic rate in males (r = 0.89, p <
0.0001) and females (r = 0.86, p < 0.0001) (Figure
7A). However, as can be seen in the figure, the
relationship is different between males and females. At any given body surface area, the resting
metabolic rate is higher in males than in females ( p
< 0.0001). Thus, body surface area is probably a
good estimate of metabolic body size and could be
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used to normalize rates of insulin-mediated glucose disposal, but only if comparing subjects of the
same sex.
An alternative way to estimate metabolic body
size is to calculate the fat-free body mass using

body composition techniques such as densitometry. Similar to body surface area, the fat-free
body mass is closely correlated with the resting
metabolic rate in males ( r = 0.87, p < 0.001) and
females (r = 0.85, p < 0.0001) (Figure 7B). In this
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Figure 7B. The relationship between resting metabolic rate determined by indirect calorimetry and
fat-free body mass determined by densitometry in 117 nondiabetic Pima males
and 96 non-diabetic
Pima females (X) (see Table I for subject characteristics). In males, Y = 0.87, p 0.0001; and in females, r =
0.85, p < 0.0001. The relationship is the same in males and females, and the equation relating resting
metabolic rate (RMR) to fat-free body mass (FFM) is: RMR = 1.4 FFM + 0.08 (giving a x axis intercept of
-17.7 kg).
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relationships within one sex. The only exception to
these guidelines would be if the metabolic rate
were increased or decreased due to disease processes. In this situation the metabolic rate does not
accurately reflect metabolic body size. For example, this complication obtains when studying subjects with untreated diabetes mellitus and marked
fasting hypergly~emia.",'~In this situation, it is
probably best to use the metabolic body size as
estimated by: fat-free body mass + 17.7 kg.

instance, however, the relationship between these
two variables is similar in males and females.
Thus, in estimating the metabolic body size, the
fat-free body mass has an advantage over using
body surface area, in that it is similar between
sexes. Thus comparisons of normalized data can
be done on data from mixtures of males and
females if the fat-free body mass is used.
It must be remembered, however, that the
relationships between metabolic rate and fat-free
body mass has an intercept significantly different
from zero. Unless this intercept is taken into
account when estimating the metabolic body size
from fat-free body mass, the metabolic body size
will be underestimated in those with a smaller
fat-free body mass in comparison to those with a
larger fat-free body mass. Each investigator should
establish the magnitude of this intercept in hidher
own laboratory to make the necessary correction.
In summary, to best normalize rates of insulin-mediated glucose disposal, it is preferable to
estimate the metabolic body size by measuring the
metabolic rate of the body. Since this may not
always be possible, the next best estimate of metabolic body size is: fat-free body mass + 17.7 kg.
The 17.7 kg corrects for the intercept in the relationship between fat-free body mass and resting
metabolic rate (at least in Pima Indians). Lastly,
surface can be used-but only when analyzing

IV. RELATIONSHIP BETWEEN DEGREE OF
OBESITY AND INSULIN ACTION

The relationship between degree of obesity
and in vivo insulin action has been studied in a
large group of nondiabetic male and female Pima
Indians (Table I). Degree of obesity was estimated
by densitometry and in vivo insulin action was
measured using a two-step, hyperinsulinemic, euglycemic clamp technique. In vivo insulin action,
at physiologic plasma insulin concentrations is
expressed as either mg/kjoule (Figure 8A) or as
mg/minute X (kg - ffm + 17.7 kg) (Figure 8B). As
seen in the figures, there is a significant, negative,
nonlinear relationship between degree of obesity
and in vivo insulin action at these physiologic
insulin concentrations, as previously described in
a smaller group of Pima males.21Note that at a
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Figure 8A. The relationship between insulin-mediated glucose disposal during the hyperinsulinemic,
euglycemic clamp and percent body fat determined by densitometry in 213 nondiabetic Pima males and
females (r = -0.61, p < 0.0001). The rate of insulin-mediated glucose disposal is normalized to the
metabolic rate as determined by indirect calorimetry and therefore is expressed as mg/kjoule. The mean
plasma insulin concentration was 126 -C 3 uU/ml and the mean plasma glucose concentration was 95 0
mg/dl.
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Figure 8B. The relationship between insulin-mediated glucose disposal rate during the hyperinsulinemic, euglycemic clamp and percent body fat determined by denistometry in 213 nondiabetic Pima
males and females ( r = -0.61, p < 0.0001). The rate of insulin-mediated glucose disposal is normalized
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is much weaker at these higher insulin concentrations than at physiologic insulin concentrations.
It is important to realize that degree of obesity
only accounts for -36% of the variance of insulin
action at physiologic insulin concentrations; and
even less, -15%, at maximally stimulating insulin
concentrations. As we have published elsewhere,22there is a significant familial, and possibly

percent body fat less than -30%, there is a decline
in insulin action with increasing obesity, whereas
above a percent body fat of -30% this relationship
does not exist.
At maximally stimulating plasma insulin concentrations there is a significant, negative linear
relationship between degree of obesity and insulin
action in males (Figure 9A and B). The relationship
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Figure 9A. The relationship between maximal insulin-stimulated glucose disposal rate during the
hyperinsulinemic, euglycemic clamp and percent body fat in 213 nondiabetic Pima males and females
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as measured using indirect calorimetry and is expressed as mg/kjoule. The mean plasma insulin
concentration was 1981 35 uU/ml and the mean plasma glucose concentration was 95 -C 0 mg/dl.

*

526

OBESITY AND INSULIN RESISTANCE IN PIMAS

0
0

0

0
0 0

0

0

0
0
00000

00
0 0 0 0
0

0

0 0 0
0
0
0

m

0 0
0

0

0

0

0 00

0

rct.

1

12.5

I

0
0

0

00
0 0 0
000

0
0
~

0

0

0

I

22.5

0

0

000

o

0

0

0 0 0

32.5

I

42.5

I

52.5

Body Fat (%)

Figure 9B. The relationship between maximal insulin-stimulated glucose disposal rate during the
hyperinsulinemic, euglycemic clamp and percent body fat determined by densitometry in 213 nondiabetic Pima males and females ( r = -0.30, p < 0.0001). The rate of insulin-mediated glucose disposal is
normalized to the fat-free body mass plus 17.7 (see text). The mean plasma insulin concentration was
1981 k 35 uu/ml and the mean plasma glucose concentration was 95 k 0 mg/dl.

genetic, component that accounts for a significant
portion of the variance of in vivo insulin action not
accounted for by degree of obesity (Figure 10).
V. BODY FAT DISTRIBUTION AND INSULIN
RESISTANCE

Jean Vague reported many years ago that
subjects with non-insulin-dependent diabetes
mellitus have a more centralized distribution of
body fat compared to nondiabetics.= This was
subsequently confirmed by Feldman et al.24 In
more recent years, Evans et al.25have reported that
women with truncal or upper-body distribution of
body fat are more insulin-resistant than equally
obese women with predominantly lower body
obesity. We have assessed the relationship between truncal versus lower body obesity and total
body fat and insulin resistance in a large group of
nondiabetic Pima Indian males and females. Body
fat distribution was estimated by measuring the
supine, waist circumference at the level of the
umbilicus. This was divided by the thigh circumference immediately below the gluteal fold.
The relationship between waist/thigh circumference (WTC) and percent body fat in Pima males
and females is shown in Figure 11. In males, WTC
is linearly, closely correlated with percent body fat
( r = 0.71, p < 0.0001). Conversely, in Pima females
WTC is poorly correlated with percent body fat (r
= 0.22, p < 0.03). Thus, knowing that WTC in

Pima males provides little more information than
knowing percent body fat, and vice versa. In Pima
females, WTC is nearly independent of degree of
obesity, so that knowing the WTC may add further
information regarding relationship between body
fat and other metabolic variables.
In Pima males, WTC is not significantly correlated with in vivo insulin action independent of
degree of obesity. This is true both at physiologic
and at maximally-stimulating insulin concentrations. In females, WTC is significantly correlated
with insulin action at physiologic ( p < 0.04) and
maximally-stimulatinginsulin concentrations ( p <
0.02), independent of degree of obesity. The reason(s) for the association of central obesity with
reduced insulin action is (are) unknown. In particular, it is not established whether they are causally
related to each other or only are both secondary to
a pathogenic third factor.
VI. MECHANISMS OF INSULIN RESISTANCE
A. Glucose Oxidation and Storage

Felber et a1.26and Boden et al.27demonstrated
that diabetic subjects have reduced storage of
glucose after an oral glucose load. We compared
the rates of oxidation and storage of glucose during the euglycemic clamp in lean and obese subjects with normal glucose tolerance.'* There was a
wide range of insulin resistance in the group. In
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subjects with the lowest glucose uptake rates during hyperinsulinemia, there was almost no glucose
storage. This added to the observations of Thiebaud et aLZ9and Jacot et al.30in lean young men
whose glucose storage was never less than 55% of
glucose uptake. Over the range, from those subjects with the greatest in vivo insulin resistance to
those with the least insulin resistance, storage
made a progressively greater contribution to glucose uptake. This study suggested that even in
subjects with normal glucose tolerance, storage
has a critical role in distinguishing between those
who are insulin resistant and those who are not.
Since other studies have shown that under the
conditions of a clamp there is little hepatic uptake
but significant peripheral glucose ~ p t a k e , ~these
'-~~
studies emphasize the role of skeletal muscle glucose storage in determining insulin resistance.
8. The Role of Fatty Acid Oxidation in

Regulating Glucose Uptake
It has been proposed that increased availability of free-fatty acids or ketones for oxidation
may be responsible for an inhibition of carbohydrate metabolism in muscle, thus producing a
reduction in glucose tolerance. The concept has
been extended to suggest that one role of insulin is
to control glucose uptake by controlling in the rate
of release of fatty acid from adipose tissue.3Mo
As we have noted, glucose disposal has components of both glucose oxidation and glucose
storage. There is good evidence for a role of lipid
oxidation in the regulation of the oxidative component, and we find strong correlations of glucose
oxidation and liquid oxidation rates. (Such correlations are not simply due to the method of
calculating lipid and carbohydrate oxidation, since
for each individual the respiratory quotient and
total oxygen consumption vary independently. We
have discussed this in more detail el~ewhere.~')
As
recently noted, nonoxidative glucose disposal
might have several components-lactate formation and muscle glycogen f~rmation.~'
The lack of
correlation and lipid oxidation with storage4' could
be due to there being opposing actions of lipid
oxidation on components of nonoxidative glucose
disposal. Alternatively, the lack of correlation
could be due to fatty acids not affecting nonoxidative disposal at all.
There is some suggestion, however, that ketones may promote glycogen formation.36There
are several conflicting reports about the effect of
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fatty acids on glucose storage. In one report,
maintaining basal FFA concentrations during hyperinsulinemia reduced oxidation, but did not
affect storage.42Similar conclusions were drawn
from a study examining the effect of age on substrate disposal.43 In another report, storage was
reduced by fatty acid infusionu; in this study,
however, subjects did not serve as their own
controls, and fatty acid levels were raised to levels
higher in general than basal levels.
Furthermore, a biochemical basis for a role of
lipid oxidation in regulating glucose storage is
lacking. On the other hand, a correlation of pyruvate dehydrogenase activity with glucose oxidation rates, and of glycogen synthesis activity with
glucose storage rates has recently been demon~ t r a t e d In
. ~ ~conclusion, it seems that the components of glucose uptake, namely glucose oxidation and storage, are probably regulated by
different mechanisms. If this is true, then the
glucose fatty acid-ketone cycle may at best have
only a partial role in producing insulin resistance.
Finally, we have recently shown that the proportion of 24 hour calorie expenditure derived
from fat (24 hr R.Q.) is not correlated with degree
of obesity (% fat). Therefore the insulin resistance
found in obese Pima Indians is not due to the
glucose-fatty acid-ketone
C. Glucose Disposal and Muscle
Glycogen Synthase

Since current evidence suggests a crucial role
for skeletal muscle in insulin-mediated glucose
d i ~ p o s a l , ~and
~ " ~since glucose storage is also an
important component of glucose disposal, it is
logical to examine the role of glycogen synthesis
and its regulatory enzyme, glycogen synthase, in
insulin action in muscle. That whole body uptake
of glucose can reasonably be assumed to reflect
muscle glucose metabolism comes from the observation that forearm or leg glucose disposal is
well-correlated with whole body glucose dispo~ a l , ~and
* * that
~ during intravenous glucose infusion the liver takes up little glucose33 but the
muscle does take up glucose.31
There is now considerable evidence in both
Pima Indians and Caucasians that glycogen synthase enzyme from vastus lateralis is activated by
insulin infusions, and activated in proportion to
the ability of insulin to stimulate glucose uptake
during the euglycemic clamp or related techniques
For example, we showed that
(Figure 12).41,45-51
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phosphate levels in muscle fall rather than rise
with the activation of glycogen synthase, and that
increasing glucose uptake by increasing plasma
glucose concentrations does not in itself increase
glycogen ~ynthase.~',~'
These studies indicate that
activation of glycogen synthase is dependent on
insulin stimulation, rather than glucose uptake per
se. Future work, aimed at determining the biochemical step at which defects in activation of
glycogen synthase occur, will help to determine
the specific biochemical defects in insulin resistance. Given that glucose uptake at supraphysiological insulin concentrations is highly familial"
and the major role of glucose storage and glycogen
synthase activation at these insulin concentrations,
it seems possible that a specific genetic defect that
determines insulin resistance in many individuals
may be located at a step between the insulin
receptor and glycogen synthase activation.
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after glycogen-depleting exercise, the rate of glucose uptake and storage was correlated with the
proportion of active enzyme present prior to insulin-glucose infusion.47We subsequently showed
that in a group of normal and diabetic subjects
without exercise, glucose uptake and storage were
correlated with muscle glycogen synthase activity
after insulin stimulation and with the change in
muscle glycogen synthase activity during insulin
~ t i m u l a t i o nWe
. ~ ~then measured the effect of the
induction of insulin resistance by overfeeding on
glycogen synthase. Overfeeding produced a reduction in the percent of active glycogen synthase.45
Taken together, these data indicate an important relationship between the regulation of glycogen synthase enzyme and in vivo insulin action.
Further studies have indicated that glucose-6-

D. Insulin Action and Muscle Fiber Type
There is good evidence for a relationship between insulin action and muscle fiber type in
animals. Fibers that differ by staining and contractile properties (twitch speed) show differences in
oxidative capacity, capillary supply, tyrosine kinase activity, and insulin stimulated glucose uptake.5240In animals, fibers of different twitch characteristics differ in their insulin sensitivity and
responsiveness, although the mechanism is unknown. We have demonstrated a correlation of
fiber type and glucose uptake at physiological and
supraphysiological insulin concentrations (for percent type I fibers: r = 0.29, p < 0.02, r = 0.29, p <
0.03, respectively; for IIB fibers: r = -0.38, p <
0.003, r = -0.32, p < 0.01, respectively) (Figure
13).61Whether this is a direct effect, or an effect of
an association with obesity or capillary density, is
not certain since in our data both obesity (Figure
14) and capillary density correlated with fiber type
(for type I fibers: r = -0.32, p < 0.01, r = 0.39, p <
0.002, respectively; for type IIB fibers: r 0.32, p <
0.02, r = -0.27, p < 0.04, respectively) (findings
illustrated in Figure 14B). However, since fiber
type may be inherited,62 the findings might also
provide a mechanism for the familial dependence
of insulin action.22

E. Insulin Action and Muscle Capillary Density
Several human studies have indicated that
muscle cell size and muscle capillary supply are
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tion (r = -0.46, r = -0.47, p 5 0.0001 for both).
Capillary density was lower in the most obese (r =
-0.59, p I0.0001) (Figure 17) (illustrated in Figure
14B)and muscle cell size was greater (r = 0.39, p <
0.002).
These data may be interpreted in several
ways. Capillary density is correlated with oxidative capacity of muscle ce11s.52,53,59,60
These correlations therefore might be due to a correlation
between some biochemical mechanism associated
with oxidative capacity and insulin action, but
there is currently no evidence to support this

associated with changes in fasting insulin concentrations and glucose t o l e r a n ~ e . We
~ ~ 'have investigated the relationship of muscle capillary density
in vastus lateralis and in vivo insulin action measured by the euglycemic hyperinsulinemic
clamps6' We found the capillary density very significantly correlated with insulin-mediated glucose
uptake at physiological (Figure 15) and supraphysiological plasma insulin concentrations (r =
0.63, I = 0.47, p I0.0001 for both). Capillary
density also correlated significantly with fasting
glucose (Figure 16) and fasting insulin concentra-
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action in our data, this is not a wholly satisfactory
explanation for the findings.
Reduced capillary density might indicate that
blood flow to skeletal muscle is reduced. At rest
not all capillaries have significant f l o ~ ~and
~,~'
anatomical studies do not permit an assessment of
which or how many capillaries are in use. Substrate uptake into tissues is regulated both by

contention. An alternative explanation is that since
oxidative capacity and twitch characteristics are
~orrelated,~
then
~ - ~perhaps
~
the induction of slow
twitch genes also induces some biochemical
changes that lead to alteration in insulin insensitivity (such as tyrosine kinase activity).57Since the
correlation of capillary density and insulin action
was stronger than those of fiber type and insulin
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the principle first proposed by Krogh”-that since
capillaries are aligned parallel to muscle fibers,
each capillary supplies a cylinder of tissue. This
cylinder varies in radius with the capillary density.
With enlargement of muscle cells, the surface
to volume ratio of cells is decreased. Therefore, to
obtain equivalent insulin action or glucose uptake
per unit muscle mass, the insulin actiodconcentration or glucose uptake per unit cell surface
area must be increased. Therefore, enlargement of
muscle cells irrespective of the capillary supply
will reduce insulin action.
With greater inter-capillary distances, there is
a greater distance for insulin or glucose to diffuse

blood flow and its ability to diffuse into the tisA low extraction ratio,68i69
i.e., a small or
modest decrease of insulin or glucose concentration between artery and vein, is direct evidence
that diffusion, and not blood flow, may be primarily limiting their uptake.70 Recently, James et al.
reported that blood flow was not a factor in determining insulin resistance in rats.71 We suggest
therefore that a possible explanation for the association of insulin resistance with capillary density
relates to biophysical changes in muscle that result
from enlarged muscle cells and greater diffusion
distances from capillaries to tissues. The following
interpretations of capillary density are based on
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to all parts of muscle cells. Diffusion of insulin or
phatic peaks are delayed 30-45 minutes (Figure
glucose over 50U to 100U-the distance between
18).78,79Glucose peaks in limb lymph are not
capillaries-would be rapid in simple aqueous
delayed like this. Neither is there this much delay
solutions. The cleft between muscle fibers may,
in insulin appearance in lymph draining the liver
however, be very narrow (?l-0.1U),73 and this
(where capillaries are fenestrated), nor in thoracic
could possibly slow the rate of diffusion of insulin.
duct lymph.78,79In the basal state, limb lymph
More important than just the diffusion disinsulin concentrations are apparently lower than
tance, however, is the effect that an increased
arterial concentration^.^',^^ Since lymphatics do not
distance between capillaries might have on the
drain interfiber areas," the differences between
ability of insulin to equilibrate within the muscle
arterial insulin and deep muscle insulin may be
tissue. Two factors are involved in this equilieven more marked than lymphatic insulin indibration: (1) when blood insulin concentration
cates.
changes, insulin must pass through capillary walls
Studies of insulin kinetics'' have indicated
and deep into interfiber clefts; and (2) muscle cell
that insuiln equilibrates slowly (greater than 60
membrane is presumably constantly taking up
minutes) with a nonvascular compartment. Gluinsulin and degrading it. Capillaries in skeletal
cose uptake closely follows the calculated insulin
muscle are ~ n f e n e s t r a t e d hence
, ~ ~ they present a
concentration in this compartment which was
barrier between blood plasma and cell wall, espethought to represent interstitial space in muscle
cially for larger molecules such as insulin.
and adipose tissue (Figure 19).81
These two lines of
There are several lines of evidence that sugevidence indicate that diffusion of insulin into
gest that insulin penetrates the capillary wall
skeletal muscle is sufficiently slow to have imporslowly and equilibrates in tissues slowly. In spite
tant physiological effects.
of active transport of insulin through the capillary
If muscle cell membranes are able to take up
wall,75current evidence suggests that diffusion of
and degrade insulin more rapidly than the diffuinsulin through the capillary wall is the same or
sion of insulin from capillary to interstitial space
worse than inulin a molecule of similar s i ~ e .On
~ ~ ' ~and down between fibers, then the following prininsulin infusion, arterial insulins are not matched
ciples apply at steady state: (1) there is a concentraby equivalent peaks in limb lymph and the lymtion drop of insulin across the capillary wall; (2)
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with reduced capillary density, each capillary has a
larger volume of tissue and greater area of cell
membrane to supply-and the insulin concentrations drop is likely to be greater; (3) there will be a
further concentration drop of insulin between interstitial space adjacent to the capillary and the
most distance parts of the muscle cell; (4)this drop
will be exaggerated with greater diffusion distances; (5) if so, the overall effect is that the
average insulin concentration around a muscle cell
with a poorer capillary supply will be reduced
even at steady state (Figure 20). We propose that
the correlations of fasting glucose, fasting insulin,
and insulin resistance measurements with capillary density may be explained by these mechanisms.
Our discussion thus far has been concerned
with the effect of capillary density on insulin
access to muscle. We now wish to extend this to
suggest that insulin action is reduced in obese
subjects because lower capillary density results in
reduced access of insulin to the muscles of obese
subjects. Obese subjects have an increased size of
visceral cells,82 and several studies also indicate
muscle cells are enlarged in the ~ b e s e . ~ 'This
,~~'
increase in muscle fiber size is not simply due to

increased tissue fat which is found in only small
amounts in skeletal muscle.52 Fat-free mass increases with obesity (Figure 4)83;and since muscle
cells do not multiply,84 they must hypertrophy.
The number of capillaries per fiber was not increased in obesity in our data, so that obese
subjects had lower capillary densities ( r = -0.59, p
I0.0001).61 We propose therefore that at least
some of the insulin resistance associated with
obesity is explained by the effects of capillary
density on insulin action.
There are several other observations that
might be explained by an association of obesity
with reduced capillary density. We have reported
that obesity explains much less of the variability of
insulin action at supraphysiological plasma insulin
concentration (-19%) than at lower plasma insulin
concentrations (-43%).22 This might be because
very high insulin concentrations overwhelm the
effects of capillary density on insulin diffusion and
the effect of decreased surface to volume ratio of
muscle cells on insulin action.
Several studies have observed a delay in onset
of insulin action in obese subjects. Prager et al.85
noted that the onset of insulin action was delayed
in the obese. Higher insulin concentrations in both
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reduction of tissue insulin in the obese for the same plasma i n s ~ l i n ) . 'mf,
~ muscle fiber; w, width of
interfiber space. Cc, capillary insulin concentration; Co, insulin concentration immediately outside
capillary; Cr, concentration of insulin at radial distance R; Rc, capillary radius; Rt, radius of tissue
cylinder. The development of this mathematical model is based on the principles that insulin diffuses
from the capillary and is taken up and degraded by muscle cell membrane. We are grateful to Dr.
Timothy Secomb of the Department of Physiology at the University of Arizona in Tucson for his
theoretical analysis of possible insulin gradients in muscle.
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Figure 21. Time course of glucose uptake in lean and obese subjects at four insulin infusion rates: -15,
40, 120, and 1,200 mU/m2/minute.The insulin infusions were started at a constant rate (i.e., not primed
as in Figure 18), but T1/2 to reach an insulin steady state was the same in lean and obese. Note the
delayed activation of glucose uptake in the obese and the fact that higher insulin infusions appear to
overcome this delay. (Redrawn from Prager R, Wallace P, and Olefsky JM, Clin Invest, 78:472-481,1986
by permission of the American Society for Clinical Investigation.) Compare this figure with Figure 19.
These data suggest reduced penetration of insulin into skeletal muscle in obesity. Furthermore, kinetic
analyses suggest that in the obese at steady state tissue insulin concentrations are reduced at any given
plasma insulin concentration compared to lean subject^.'^

the lean and the obese accelerated the onset of
insulin action, suggesting that higher concentrations could overcome the kinetic defect (Figure 21).
A comparison of Figures 19 and 21 suggests insulin’s equilibration in muscle is delayed in the
obese. Parenthetically insulin action is not delayed
in obese subjects in the liver-an organ with
fenestrated capillaries even though glucagon does
not suppress as well in the obese.85Doeden et a1.86
also noted a delayed onset of action of insulin in
obese subjects, the effect of which was most noticeable while changing plasma insulin concentrations.
Finally, studies of whole-body insulin kinetics
suggest that in obese subjects the steady-state
insulin concentration in tissue is reduced relative
to plasma in obese subjects compared to lean
subjects. The obese subject’s tissue insulins are
26% lower than in lean subjects at the same plasma
insulin c ~ n c e n t r a t i o nQualitatively
.~~
this is what
we have predicted might occur if capillary density
is reduced (Figure 20). All of these studies suggest
that in obese subjects the insulin penetration into
skeletal muscle is reduced and its equilibration in
muscle may be slowed. We propose that this might

be an effect that is due to reduced capillary supply
to skeletal muscle in obese subjects.
We conclude that the correlation of insulin
resistance and basal insulin and glucose levels
with capillary density may be a result of biophysical restraints on glucose and insulin access to
cells. Furthermore, the effects of obesity on capillary density may partially explain the relationship
of insulin resistance and obesity, explain the poor
correlation of obesity and insulin action at supraphysiological plasma concentrations of insulin,
and explain the delayed onset of action of insulin
in the obese. Finally, the development of insulin
resistance and slightly elevated plasma glucose
concentrations that signal the pancreas that insulin
resistance is present might initiate a vicious cycle
of pancreatic glucose insensitivity, further hyperglycemia, and noninsulin-dependent diabetes
mellitus (see Ref. 22).
VII. SUMMARY
Diabetes and obesity are epidemic in the Pima
Indians of the Southwestern United States, and
the prevalence of diabetes is increasing. The most
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likely link between obesity and diabetes is tissue
insulin resistance.
If obesity is defined as an excess of body fat,
then it can only be accurately assessed by measurements of body composition and not by approximations such as body mass index or percent of
ideal weight.
To compare the metabolic data of individuals
of varying size, an accurate measure of metabolic
size is needed. Total body weight is not an appropriate means of comparing individuals since obese
subjects have a greater proportion of nonmetabolizing mass (triglyceride). Body surface area shows
a sex difference, and this may distort data if both
sexes are present. From studies of metabolic rate
we have determined that metabolic rate is directly
proportional to the fat-free mass plus 18 kg, and
we suggest that this weight can be equated with
metabolic size.
Glucose storage in skeletal muscle appears to
be important in the disposal of an intravenous
glucose load. Consistent with its role in glycogen
storage, glycogen synthase enzyme is activated in
proportion to the ability to dispose of glucose
during a hyperinsulinemic, euglycemic clamp. The
role of glycogen synthase is most notable at supraphysiological plasma insulin concentrations; and
since glucose uptake at these insulin concentrations is highly familial independent of the degree
of obesity, we suggest that there may be a specific
genetic defect expressed in skeletal muscle that
reduces insulin responsiveness in some subjects.
The lack of correlation between 24 hour respiratory quotient measured in a metabolic chamber
(a measure of the proportion of fat derived calories)
and degree of obesity indicates that in obese Pima
Indians insulin resistance is not due to an inhibition of glucose metabolism by free fatty acids
(glucose-fatty acid-ketone cycle).
Obesity is associated with an increase in fatfree mass almost kilogram- for kilogram with fat
mass when compared to the lean state. A role for
this increase in fat-free tissue in producing insulin
resistance has been given insufficient attention in
the past. With an increase in fat-free mass, muscle
cells are hypertrophied and capillaries in muscle
are more widely spaced. We propose that these
biophysical changes in muscle mediate, at least in
part, the effects of obesity to produce a reduction
in insulin sensitivity and the abnormal kinetics of
insulin action found in the obese. We suggest
therefore that insulin resistance is a combination of
a genetic defect and obesity-induced changes in
the biophysical properties of skeletal muscle.

These defects may in turn lead to the development
of non-insulin-dependent diabetes mellitus.
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